7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hemarthrosis D006395 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Prosthesis Failure D011475 1 associated lipids
Tooth Mobility D014086 2 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Hip Dislocation D006617 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Coronary Stenosis D023921 6 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Bacteremia D016470 9 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Gingival Recession D005889 2 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Hashimoto Disease D050031 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Arthralgia D018771 8 associated lipids
Osteophyte D054850 2 associated lipids
Hemophilia A D006467 10 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Encephalitis D004660 15 associated lipids
Macular Degeneration D008268 5 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Actinomycosis D000196 2 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Angina, Stable D060050 2 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Stomatitis D013280 14 associated lipids
Weight Loss D015431 56 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Respirovirus Infections D010253 3 associated lipids
Thinness D013851 11 associated lipids
Obesity, Morbid D009767 8 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastocytoma D034801 3 associated lipids
Tooth Migration D014085 2 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Tinnitus D014012 4 associated lipids
Cherubism D002636 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Tooth Resorption D014091 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Labyrinthitis D007762 2 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Foot Injuries D018409 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Rheumatic Fever D012213 1 associated lipids
Progeria D011371 3 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Periostitis D010522 1 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Venous Thrombosis D020246 11 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Microvascular Angina D017566 2 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Chronic Disease D002908 7 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Carcinosarcoma D002296 7 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Shuid AN et al. Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. 2012 BMC Complement Altern Med pmid:22967165
Biscetti F et al. Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients. 2013 Hum. Genet. pmid:22965192
Pedersen S et al. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 2012 Cardiology pmid:22964478
Feng Y et al. AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. 2012 Chin. Med. J. pmid:22964327
Chen YH et al. Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. 2012 PLoS ONE pmid:22957004
Diercke K et al. IL-1β and compressive forces lead to a significant induction of RANKL-expression in primary human cementoblasts. 2012 J Orofac Orthop pmid:22955577
Shen P et al. Expression of osteoprotegerin in placenta and its association with preeclampsia. 2012 PLoS ONE pmid:22952959
Buckle CH et al. Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. 2012 PLoS ONE pmid:22952578
Li F et al. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. 2012 Fitoterapia pmid:22951288
Deuell KA et al. RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. 2012 J. Vasc. Res. pmid:22948607
Keller KK et al. SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes. 2013 Rheumatol. Int. pmid:22948540
Zhou J et al. Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats. 2013 Rheumatol. Int. pmid:22948539
Yan J et al. Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling. 2012 J. Cell. Mol. Med. pmid:22947224
Zhang W et al. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. 2013 Inflammation pmid:22945280
Leistner DM et al. Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis. 2012 Circ Heart Fail pmid:22936827
Yao Y et al. [The effect of bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22934505
Zhang M et al. [The expression and significance of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in periapical cyst and periapical granuloma]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22934488
Cauley JA Commentary: A single biomarker in a complex metabolic pathway. 2012 Int J Epidemiol pmid:22933649
Bargman R et al. High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. 2012 Pediatr. Res. pmid:22926546
Canon J et al. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. 2012 Breast Cancer Res. Treat. pmid:22926264
Pereda GO et al. Inflammatory and bone regulators expression in murine macrophages under exposure of commercial and experimental mineral trioxide aggregate. 2012 Aust Dent J pmid:22924350
Hogrefe C et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-/multidirectional therapeutic approaches. 2012 Int. J. Mol. Med. pmid:22922824
Frederiksen L et al. Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat. 2013 Horm. Metab. Res. pmid:22918704
Vik A et al. Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. 2012 Thromb. Res. pmid:22909822
Hou JM et al. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. 2012 Acta Pharmacol. Sin. pmid:22902986
Belibasakis GN et al. The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease. 2013 Int Endod J pmid:22900632
Mayahara K et al. Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2). 2012 Arch. Oral Biol. pmid:22884709
Zhou WJ et al. [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:22883830
pmid:22878484
Bezerra JP et al. Effects of estrogen deficiency and/or caffeine intake on alveolar bone loss, density, and healing: a study in rats. 2013 J. Periodontol. pmid:22873654
Dickerson TJ et al. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. 2012 J. Autoimmun. pmid:22867712
Mozzati M et al. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. 2013 Clin Oral Investig pmid:22864527
Nanda KS et al. Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection. 2012 Cytokine pmid:22863720
Einvik G et al. Novel cardiovascular risk markers in depression: no association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea. 2013 J Affect Disord pmid:22862888
Liang W et al. Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line. 2012 Int. J. Mol. Med. pmid:22842877
Hwang JJ et al. Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients. 2012 J. Acquir. Immune Defic. Syndr. pmid:22842843
O'Sullivan EP et al. A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. 2013 Metab. Clin. Exp. pmid:22841521
Wang Y et al. Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model. 2012 Connect. Tissue Res. pmid:22827452
Chao TH et al. Opposite associations of osteoprotegerin and ZBTB40 polymorphisms with bone mineral density of the hip in postmenopausal Taiwanese women. 2012 J Chin Med Assoc pmid:22824048
Chen B et al. Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation. 2012 Phytomedicine pmid:22818895
Wang F et al. Icariin enhances the healing of rapid palatal expansion induced root resorption in rats. 2012 Phytomedicine pmid:22818561
Dieset I et al. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein. 2012 Schizophr. Res. pmid:22817875
Poerschke RL et al. Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. 2012 J. Biochem. Mol. Toxicol. pmid:22807314
Wang C et al. Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. 2012 J. Bone Miner. Res. pmid:22807154
Kleyer A et al. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. 2012 J. Bone Miner. Res. pmid:22806960
Kerschan-Schindl K Bone turnover in hyperparathyroidism. 2013 Wien Med Wochenschr pmid:22805761
Mirzaei K et al. Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. 2012 Minerva Med. pmid:22805623
Davenport C et al. The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. 2012 Eur. J. Clin. Invest. pmid:22803952
Zhu XF et al. [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803437
Xu Y et al. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803436
Deng YH et al. The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. 2013 Endocrine pmid:22798246
Kaneko K et al. Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts. 2012 J. Clin. Endocrinol. Metab. pmid:22791764
Tyagi AM et al. Formononetin reverses established osteopenia in adult ovariectomized rats. 2012 Menopause pmid:22781783
Wolf M et al. Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats. 2013 Clin Oral Investig pmid:22777389
Cui L et al. Effect of fluid flow-induced shear stress on osteoclast formation induced by osteocyte. 2012 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:22776650
Ciccone MM et al. Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases. 2013 J Cardiovasc Med (Hagerstown) pmid:22772598
Oue E et al. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. 2012 Biochem. Biophys. Res. Commun. pmid:22771802
Shen C et al. Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. 2012 Am. J. Cardiol. pmid:22762713
Baud'huin M et al. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22761317
Zhou W and Mei L Effect of autologous bone marrow stromal cells transduced with osteoprotegerin on periodontal bone regeneration in canine periodontal window defects. 2012 Int J Periodontics Restorative Dent pmid:22754911
Melchiorre D et al. RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology. 2012 J. Rheumatol. pmid:22753650
Chandran V Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. 2012 J Rheumatol Suppl pmid:22751596
Khoury N et al. Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab. 2012 J. Clin. Endocrinol. Metab. pmid:22730513
Miyaji Y et al. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. 2012 Pharm. Res. pmid:22729371
Yoon WJ et al. Sargachromanol G regulates the expression of osteoclastogenic factors in human osteoblast-like MG-63 cells. 2012 Food Chem. Toxicol. pmid:22727857
Çanga A et al. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. 2012 J Cardiol pmid:22727437
Lee MH et al. The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:22717323
Barbieri G et al. Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. 2013 Angle Orthod pmid:22716279
Martínez-Calatrava MJ et al. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. 2012 Arthritis Res. Ther. pmid:22709525
Rakic M et al. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. 2013 Clin Oral Implants Res pmid:22708989
Roodman GD Genes associate with abnormal bone cell activity in bone metastasis. 2012 Cancer Metastasis Rev. pmid:22706844
Nakashima T et al. New insights into osteoclastogenic signaling mechanisms. 2012 Trends Endocrinol. Metab. pmid:22705116
Fuernau G et al. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging. 2013 Int. J. Cardiol. pmid:22704876
Liu L et al. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin. 2012 J Endod pmid:22703658
Kwon H et al. Effect of 635 nm irradiation on high glucose-boosted inflammatory responses in LPS-induced MC3T3-E1 cells. 2013 Lasers Med Sci pmid:22699799
Cvija H et al. Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. 2012 Inflammation pmid:22699680
Olesen M et al. No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. 2012 Mol. Cell. Endocrinol. pmid:22698523
Bogliolo L et al. Biomarkers and prognostic stratification in psoriatic arthritis. 2012 Reumatismo pmid:22690385
Tanaka M et al. Effect of Reveromycin A on experimental tooth movement in OPG-/- mice. 2012 J. Dent. Res. pmid:22674934
Zhu Y et al. Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. 2013 J. Cell. Physiol. pmid:22674471
Marzaioli V et al. Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes. 2012 Arthritis Rheum. pmid:22674155
Kim H et al. The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women. 2012 Menopause pmid:22668815
Luan X et al. Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin. 2012 J. Immunol. pmid:22664871
Navratilova Z et al. Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population. 2014 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:22660233
Kim S et al. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis. 2012 Diagn. Microbiol. Infect. Dis. pmid:22647538
Yan J et al. Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone. 2012 Am. J. Pathol. pmid:22640808
Tousoulis D et al. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. 2013 Int. J. Cardiol. pmid:22640692
Galli C et al. Effect of surface treatment on cell responses to grades 4 and 5 titanium for orthodontic mini-implants. 2012 Am J Orthod Dentofacial Orthop pmid:22640672
Brunetti G et al. Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. 2012 Endocrine pmid:22638612
Wang QP et al. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. 2012 Bone pmid:22634178
Wilkison M et al. Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. 2012 Am. J. Pathol. pmid:22626807
Galli C et al. GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. 2013 Clin Oral Implants Res pmid:22626030
Ma D et al. Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice. 2012 J. Proteome Res. pmid:22616666
Ma Y et al. Effects of brucine on bone metabolism in multiple myeloma. 2012 Mol Med Rep pmid:22614932
Wang YD et al. Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway. 2012 Chin. Med. J. pmid:22613593
da Silva RA et al. Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number. 2012 J Endod pmid:22595116
Kim EC et al. Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells. 2012 J Endod pmid:22595110
Liu L et al. [Effect of gradually induced disordered occlusion on the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in mandibular condylar cartilage of rats]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22594224
Güncü GN et al. Effect of inflammation on cytokine levels and bone remodelling markers in peri-implant sulcus fluid: a preliminary report. 2012 Cytokine pmid:22592038
Motovska Z et al. Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. 2012 Int. J. Cardiol. pmid:22592030

Table of Content